Your Trusted Partner In Managing Your Healthcare Needs. See Hormone Replacement Therapy! Save Time With TelyRx. Get Your Prescription And Order Medication In Just A Few Minutes.
Search results
- Heron Therapeutics released its earnings results on Aug 06, 2024. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of -$0.039 by -$0.021. Is Heron Therapeutics overvalued? According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued.
www.tipranks.com/stocks/hrtx
People also ask
How does Heron Therapeutics (hrtx) stock compare to other companies?
What is the 12-month price forecast for heron Therapeutics (hrtx)?
Should you buy Heron Therapeutics (hrtx) in 2023?
What was Heron Therapeutics' stock price in 2024?
Is Heron Therapeutics a good investment?
Should you buy hrtx (hrtx) stock?
Potentially undervalued companies in the Pharmaceuticals-biotech industry. Research Heron Therapeutics' (Nasdaq:HRTX) stock key valuation metrics while comparing it with its industry peers & market side by side.
3 days ago · HRTX has an Altman Z-Score of -10.81 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Heron Therapeutics, Inc. (HRTX) stock, including valuation metrics, financial numbers, share information and more.
Oct 25, 2024 · Get a real-time Heron Therapeutics, Inc. (HRTX) stock price quote with breaking news, financials, statistics, charts and more.
- 274.52M
- 136.36M
- 48.13M
- 151.67M
Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024. (PR Newswire) -7.33%. Oct-10-24 04:08PM. Heron Therapeutics Reaffirms Availability and Ample Supply of CINVANTI, SUSTOL, and APONVIE as Alternatives During the Potential Shortage of Intravenous Fluids.
Find the latest Heron Therapeutics, Inc. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
According to Wall Street analysts Heron Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium Does Heron Therapeutics pay dividends?
3 days ago · The 3 analysts with 12-month price forecasts for Heron Therapeutics stock have an average target of 6.00, with a low estimate of 5.00 and a high estimate of 7.00. The average target predicts an increase of 246.82% from the current stock price of 1.73.
%20undervalued%203&ck=0163350816275ACED7512ABCC5C7D67B&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued 31")
%20undervalued%203&ck=1DEB06445E14643BE734EA62E38E9D8E&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued 32")
%20undervalued%203&ck=913321CDA9164D5F9D5E4F556E5F882D&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued 33")
%20undervalued%203&ck=6200AA32B91BC8F60E9A31228EE8DBC7&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued 34")
%20undervalued%203&ck=8B4E8E47764B3A4377A558D821DE8B88&idpp=rc&idpview=singleimage&form=rc2idp "is heron therapeutics (hrtx) undervalued 35")
